The Division of Hematology, Johns Hopkins University School of Medicine, Ross Research Building, Baltimore, MD 21205, USA.
Immunol Res. 2010 Jul;47(1-3):179-84. doi: 10.1007/s12026-009-8149-y.
High-dose cyclophosphamide (high-CY) is a potent immunosuppressive regimen that is increasingly used to mitigate both autoimmune and alloimmune conditions. Differential expression of aldehyde dehydrogenase between hematopoietic stem cells and lymphocytes accounts for the differential sensitivity of these cells to high-CY and explains why this regimen is immunosuppressive but not myeloablative. This article describes the clinical translation of high-CY for the treatment of autoimmune and alloimmune conditions.
高剂量环磷酰胺(high-CY)是一种有效的免疫抑制方案,越来越多地用于减轻自身免疫和同种免疫疾病。造血干细胞和淋巴细胞之间醛脱氢酶的差异表达解释了这些细胞对 high-CY 的敏感性差异,这也解释了为什么该方案具有免疫抑制作用但不具有骨髓清除作用。本文描述了 high-CY 治疗自身免疫和同种免疫疾病的临床转化。